ATE123341T1 - Nachweisverfahren eines zellenoberflächenantigens. - Google Patents

Nachweisverfahren eines zellenoberflächenantigens.

Info

Publication number
ATE123341T1
ATE123341T1 AT88900625T AT88900625T ATE123341T1 AT E123341 T1 ATE123341 T1 AT E123341T1 AT 88900625 T AT88900625 T AT 88900625T AT 88900625 T AT88900625 T AT 88900625T AT E123341 T1 ATE123341 T1 AT E123341T1
Authority
AT
Austria
Prior art keywords
cell surface
surface antigen
detection method
present
provides
Prior art date
Application number
AT88900625T
Other languages
English (en)
Inventor
Robert Mcmillan
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/936,125 external-priority patent/US4810632A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE123341T1 publication Critical patent/ATE123341T1/de

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
    • G02F1/31—Digital deflection, i.e. optical switching
    • G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
    • G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
    • G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
    • G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F3/00—Optical logic elements; Optical bistable devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Power Engineering (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT88900625T 1986-12-01 1987-11-25 Nachweisverfahren eines zellenoberflächenantigens. ATE123341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/936,125 US4810632A (en) 1986-12-01 1986-12-01 Cell surface antigen detection method
US07/124,905 US5176998A (en) 1986-12-01 1987-11-24 Cell surface antigen detection method

Publications (1)

Publication Number Publication Date
ATE123341T1 true ATE123341T1 (de) 1995-06-15

Family

ID=26823073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88900625T ATE123341T1 (de) 1986-12-01 1987-11-25 Nachweisverfahren eines zellenoberflächenantigens.

Country Status (9)

Country Link
US (2) US5176998A (de)
EP (1) EP0290595B1 (de)
JP (1) JP2803824B2 (de)
AT (1) ATE123341T1 (de)
AU (1) AU594554B2 (de)
DE (1) DE3751331T2 (de)
DK (1) DK173838B1 (de)
FI (1) FI95082C (de)
NO (1) NO172910C (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
US6984526B2 (en) 1995-02-08 2006-01-10 University Of South Florida Spectrophotometric method for determining the viability of a sample containing platelets
US6330058B1 (en) 1999-04-14 2001-12-11 University Of South Florida Spectrophotometric method and apparatus for blood typing
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
WO2010065425A1 (en) 2008-12-01 2010-06-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
EP3435080A1 (de) 2013-03-14 2019-01-30 The Board of Trustees of the Leland Stanford Junior University Verfahren zum nachweis von donorspezifischen antikörpern
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
EP0149168B1 (de) * 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immuntest
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
JPS6181798A (ja) * 1984-07-23 1986-04-25 ベクトン・デイツキンソン・アンド・カンパニ− 細胞リセプタ−の回収
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method

Also Published As

Publication number Publication date
DK426588D0 (da) 1988-07-29
EP0290595A4 (en) 1990-12-19
AU1087688A (en) 1988-06-30
DK426588A (da) 1988-07-29
NO883367D0 (no) 1988-07-29
DE3751331T2 (de) 1996-02-01
DK173838B1 (da) 2001-12-10
NO172910B (no) 1993-06-14
FI95082B (fi) 1995-08-31
US5336597A (en) 1994-08-09
FI883585A0 (fi) 1988-07-29
DE3751331D1 (de) 1995-07-06
NO883367L (no) 1988-07-29
US5176998A (en) 1993-01-05
NO172910C (no) 1993-09-22
FI95082C (fi) 1995-12-11
EP0290595B1 (de) 1995-05-31
FI883585L (fi) 1988-07-29
AU594554B2 (en) 1990-03-08
JPH01501571A (ja) 1989-06-01
EP0290595A1 (de) 1988-11-17
JP2803824B2 (ja) 1998-09-24

Similar Documents

Publication Publication Date Title
DK158481C (da) Fremgangsmaade til analyse af antistoffer samt reagens dertil
GB1436934A (en) Method of testing blood
GB9827228D0 (en) Cancer detection method and reagents
ES2098744T3 (es) Ensayo inmunologico en fase solida.
ATE123341T1 (de) Nachweisverfahren eines zellenoberflächenantigens.
DK155967C (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
NO932320L (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
EP0396115A3 (de) Verfahren zur Bildung von Agglutinaten in Blutproben
NO331074B1 (no) Analysemetode for bestemmelse av holo-Transcobalamin II i en cellefri prove i et kroppsfluid.
DE3270252D1 (en) Radioimmunoassay for fibrinopeptide a
NO20003709D0 (no) Detekteringssystem som benytter liposomer og signalmodifikasjon
SE8900721D0 (sv) Methods for detection of antibodies to
GR3005971T3 (de)
ES535553A0 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
SE8304190D0 (sv) Forfarande och reagens for immunologiska metningar
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
NO881998D0 (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker, og middel til gjennomfoering av fremgangsmaaten.
ATE64466T1 (de) Immuntest.
Keever et al. Hla-b44. 2 directed cytotoxic t cells associated with acute graft vs host disease following unrelated marrow transplantation
Kao et al. Enzyme-linked immunoasssay for detection and quantitation of anti-hla antibody
IT9006603A1 (it) Test immunoenzimatico classe specifico per la ricerca e determinazione degli anticorpi anti-cardiolipina nel siero.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time